Advance Search
CAO Jingyuan, ZHAO Shizhu, LU Guoyuan. Correlation between serum CD146 and abdominal aortic calcification in patients with peritoneal dialysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 73-77. DOI: 10.7619/jcmp.202023023
Citation: CAO Jingyuan, ZHAO Shizhu, LU Guoyuan. Correlation between serum CD146 and abdominal aortic calcification in patients with peritoneal dialysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 73-77. DOI: 10.7619/jcmp.202023023
shu

Correlation between serum CD146 and abdominal aortic calcification in patients with peritoneal dialysis

  • 1. Department of Nephrology, Taizhou City People's Hospital in Jiangsu Province, Taizhou, Jiangsu, 225300;

  • 2. Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215000

More Information
  • Received Date: October 20, 2020
  • Available Online: December 20, 2020
    Graphical Abstract
    • Abstract
  • Objective To analyze the correlation between CD146 and abdominal aortic calcification(AAC)in patients with peritoneal dialysis(PD). Methods Clinical and laboratory materials of patients with PD were collected, and the level of serum CD146 was detected by enzyme-linked immunosorbent assay. Abdominal computed tomography(CT)was used to evaluate the incidence and severity of AAC. Results Totally 133 eligible PD patients were selected, including 74 cases with AAC(55.6%). Among PD patients with AAC, 30 cases(40.5%)had severe AAC and 44 cases(59.5%)had non-severe AAC. The serum CD146 level of PD patients with AAC was significantly higher than that of non-AAC patients(P<0.001), while the serum CD146 level of patients with severe AAC was significantly higher than that of patients with non-severe AAC(P=0.021). Multivariate Logistic regression analysis showed that increasing age, prolonged duration of peritoneal dialysis, increasing serum phosphorus and increasing CD146 level were associated with the increased risk of AAC(P<0.05 or P<0.01). The risk of severe AAC reduced significantly when albumin increased in PD patients(P=0.015). The increased CD146 level was associated with an increased risk of severe AAC(P=0.005). Conclusion Serum CD146 is associated with an increased risk of AAC and severe AAC in PD patients, and the level of serum CD146 could be used as an early indicator of AAC in PD patients.
    • FullText(HTML)
    • References (28)
  • ROBINSON B M, AKIZAWA T, JAGER K J, et al. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices[J]. Lancet, 2016, 388(10041): 294-306.
    TANG S C W, YU X Q, CHEN H C, et al. Dialysis care and dialysis funding in Asia[J]. Am J Kidney Dis, 2020, 75(5): 772-781.
    MEHROTRA R, DEVUYST O, DAVIES S J, et al. The current state of peritoneal dialysis[J]. J Am Soc Nephrol, 2016, 27(11): 3238-3252.
    LOZIER M R, SANCHEZ A M, LEE J J, et al. Comparison of cardiovascular outcomes by dialysis modality: a systematic review and meta-analysis[J]. Perit Dial Int, 2019, 39(4): 306-314.
    KETTELER M, BLOCK G A, EVENEPOEL P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)Guideline Update: what's changed and why it matters[J]. Kidney Int, 2017, 92: 26-36.
    NIU Q Y, HONG Y, LEE C H, et al. Abdominal aortic calcification can predict all-cause mortality and CV events in dialysis patients: a systematic review and meta-analysis[J]. PLoS One, 2018, 13(9): e0204526.
    VERBEKE F, VAN BIESEN W, HONKANEN E, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease(CORD)study[J]. Clin J Am Soc Nephrol, 2011, 6(1): 153-159.
    LEROYER A S, BLIN M G, BACHELIER R, et al. CD146(cluster of differentiation 146)[J]. Arterioscler Thromb Vasc Biol, 2019, 39(6): 1026-1033.
    BARDIN N, MOAL V, ANFOSSO F, et al. Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration[J]. Thromb Haemost, 2003, 90(5): 915-920.
    马莹, 陈丽萌. CD146与肾脏微血管损伤的研究进展[J]. 中华肾脏病杂志, 2017, 33(3): 229-231.
    SAITO O, SAITO T, OKUDA K, et al. Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans[J]. Clin Exp Nephrol, 2008, 12(1): 58-64.
    QIAN Y N, LUO Y T, DUAN H X, et al. Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability[J]. CNS Neurosci Ther, 2014, 20(5): 438-445.
    DAVILA J A, JOHNSON C D, BEHRENBECK T R, et al. Assessment of cardiovascular risk status at CT colonography[J]. Radiology, 2006, 240(1): 110-115.
    HENDRIKS E J E, DE JONG P A, BEULENS J W J, et al. Annularity of aorto-iliac arterial calcification and risk of all-cause and cardiovascular mortality[J]. JACC Cardiovasc Imaging, 2018, 11(11): 1718-1719.
    NASRALLAH M M, NASSEF A, ELSHABONI T H, et al. Comparing different calcification scores to detect outcomes in chronic kidney disease patients with vascular calcification[J]. Int J Cardiol, 2016, 220: 884-889.
    YAO Z H, WANG C X, ZHANG Q N, et al. Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis[J]. Int Urol Nephrol, 2017, 49(11): 2061-2069.
    LUMLERTGUL D, KANTACHUVESIRI S, APICHAIYINGYURD S, et al. Prevalence of and predictive factor for abdominal aortic calcification in Thai chronic kidney disease patients[J]. Ther Apher Dial, 2017, 21(6): 611-619.
    LIU Z H, YU X Q, YANG J W, et al. Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study[J]. Curr Med Res Opin, 2018, 34(8): 1491-1500.
    KAROHL C, D'MARCO GASCÓN L, RAGGI P. Noninvasive imaging for assessment of calcification in chronic kidney disease[J]. Nat Rev Nephrol, 2011, 7(10): 567-577.
    MOODY W E, EDWARDS N C, MADHANI M, et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: Cause or association?[J]. Atherosclerosis, 2012, 223(1): 86-94.
    SORIANO S, CARMONA A, TRIVIÑO F, et al. Endothelial damage and vascular calcification in patients with chronic kidney disease[J]. Am J Physiol Renal Physiol, 2014, 307(11): F1302-F1311.
    DISTHABANCHONG S, SRISUWARN P. Mechanisms of vascular calcification in kidney disease [J]. Adv Chronic Kidney D, 2019, 26(6): 417-426.
    VAN DEN BERGH G, OPDEBEECK B, D'HAESE P C, et al. The vicious cycle of arterial stiffness and arterial media calcification[J]. Trends Mol Med, 2019, 25(12): 1133-1146.
    LUO Y, TENG X, ZHANG L, et al. CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension[J]. Nat Commun, 2019, 10(1): 3551.
    LUO Y T, DUAN H X, QIAN Y N, et al. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis[J]. Cell Res, 2017, 27(3): 352-372.
    SAITO T, SAITO O, KAWANO T, et al. Elevation of serum adiponectin and CD146 levels in diabetic nephropathy[J]. Diabetes Res Clin Pract, 2007, 78(1): 85-92.
    王漪芸, 费杨, 范瑛, 等. 糖尿病肾病患者血浆可溶性CD146水平与动脉粥样硬化及其预后的关系[J]. 中华糖尿病杂志, 2018, 10(4): 274-279.
    WANG M J, OBI Y, STREJA E, et al. Association of parameters of mineral bone disorder with mortality in patients on hemodialysis according to level of residual kidney function[J]. Clin J Am Soc Nephrol, 2017, 12(7): 1118-1127.
    • Related Articles

  • Related Articles

    [1]HU Yangxi, LIU Yan, LI Mengzhu, DONG Xing, LI Ran, WANG Wenjuan, YE Jianping, LIU Hansong. Efficacy analysis of laparoscopic sleeve gastrectomy in treating patients with obese polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 49-52. DOI: 10.7619/jcmp.20234176
    [2]ZHOU Lina, HAN Yanhua, GENG Tiantian, LIU Li. Research progress in effects of hyperandrogenin and insulin resistance on placental pathology of polycystic ovary syndrome
    [J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 137-141. DOI: 10.7619/jcmp.20223478
    [3]CAI Hua, BAI Wenpei, YU Qi, RUAN Xiangyan, YANG Xin, FENG Limin, GU Bei, LI Jian, WU Jie, ZHANG Ju, HAO Lijuan, ZHOU Hanying, YANG Rui, GAO Hongwei, CHEN Ying, ZHANG Wei, HUANG Yuanhua, ZHANG Jie, QU Qinglan, WANG Yunfang, XIE Yanfei, CUI Yuqian, LI Zengning, GUO Zengqing, ZHOU Li, SONG Xinna, ZHANG Pianhong, MA Xianghua, ZHENG Xuan, WENG Min, ZHU Cuifeng, CHEN Qiuxia, DAI Minhui, HUANG Xiaoli, JIANG Bo. Chinese expert consensus of ketogenic diet intervention for polycystic ovary syndrome (2022 revision)[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 1-10. DOI: 10.7619/jcmp.20230890
    [4]Metabolic associated polycystic ovarian syndrome and its theoretical basis[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 1-4,9. DOI: 10.7619/jcmp.20210388
    [5]GAO Zhifei, WANG Weicheng. Clinical, endocrine as well as metabolic characteristics and treatment of adolescent polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 68-71. DOI: 10.7619/jcmp.201914018
    [6]JIA Xiaolin, LI Na. Clinical efficiency of laparoscopic ovarian perforation combined with clomiphene citrate and human chorionic gonadotropin in treating infertility induced by polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 102-105. DOI: 10.7619/jcmp.201907027
    [7]BAI Liran, LI Jian, NIU Litian, WANG Aili, WU Fengyun, BAI Wenpei, JIANG Bo. Preliminary report of a single-center clinical study for ketogenic diet intervention of polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 2-5. DOI: 10.7619/jcmp.201907002
    [8]Minawaer·Aizezi, Guzailinuer·Maimaitituersun, Hanikezi·Tuerxun. Effects of letrozole combined with high-purity menotrophin on the pregnancy and reproductive hormones changes in patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2017, (13): 76-79. DOI: 10.7619/jcmp.201713020
    [9]YU Jie, ZHOU Xingwei, ZHANG Kun, ZOU Lei, HUANG Xue. Value of ultrasound diagnosis of endometrial thickness and ovarian blood changes in treatment of patients with polycystic ovary syndrome[J]. Journal of Clinical Medicine in Practice, 2016, (13): 77-79. DOI: 10.7619/jcmp.201613022
    [10]GAN Qiye. Effect of laparoscopic ovarian electrocautery on treatment of patients with refractory polycystic ovarian syndrome[J]. Journal of Clinical Medicine in Practice, 2014, (19): 143-145. DOI: 10.7619/jcmp.201419047

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return